The Landscape of Clinical Trial Data Sharing Initiatives
|
|
- Sharyl Stephens
- 8 years ago
- Views:
Transcription
1 2 T R I A L D ES I G N & R EG I S TRAT I O N P A R T I C I P ANT EN R O L L M EN T M E T A D ATA R EG I STRAT I O N EL EM EN TS DATA S H A R I N G P L A N I N D I V I D U A L P A R T I C I PA NT D A T A L AY S UMMA R I ES S U M M A R Y D A T A S UMMA RY- LEV EL R ES U LTS P UB L I C AT I O N P OST- P UB L I C AT I O N DATA P ACKAG E F UL L DATA PACKA GE P OST- R EG UL ATO RY DATA P ACKAG E not int e n d e d t o s u p p o r t r e g u l a t ory a p p l i c a t i o n s and r e g a r d l e s s o f p u b l i c a t i o n t i m i n g r ela tiv e t o s t u d y c o m p l e t i o n, t h o u g h p u b l i c a tion is mos t likely t o o ccur aft e r s t u d y c o m p l e t i o n. o r 18 m o n t h s aft e r s t u d y c o m p l e t i o n, w h i c h e v e r is la t er; 18 m o n t h s aft e r a b a n d o n m e n t o f the p r oduct o r i n d i c a t io n. T his a p p l i e s t o all s t u d i e s int e n d e d and t o s u p p o r t r e g u l a t ory a p p l i c a t i o n s, e v e n if a b a n d o n m e n t o c c u r s p r i o r t o a c t u a l r e g u l a t ory a p p l i c a t io n. YES 5/16/2015 Clinical Trial Life Cycle: When to Share Data IOM Report C L I N I C A L T R I A L M I L E S T ONE The Landscape of Clinical Trial Data Sharing Initiatives 1 2 S TUDY CO M P L ET I O N O R T ER M I N AT I O N 3 4 R E G U L A TO R Y A P P L I C A T I O N? N O 5 B 5 A Ravi Shankar W H E N T O S H A R E WHA T T O S H A R E At t r i a l re g i s t rat i o n 1 2 m o n t h s afte r s t u d y c o m p l e t i o n 6 M o n t h s afte r p u b l i c a t i o n * 1 8 m o n t h s afte r s t u d y c o m p l e t i o n 1 8 m o n t h s aft e r p ro d u c t a b a n d o n m e n t O R 3 0 d a y s aft e r re g u l a t ory a p p r o v al* * Research Scientist Stanford University School of Medicine KEY : * N o l ate r t h an 6 m o n t h s aft e r pu bl i c at i o n a p p l i e s t o all s t u d i e s, w h e t h e r int e n d e d o r ** S h ar i n g the pos t - r e g u l a t ory d a t a pac k age s h ou l d o c cur 3 0 d a y s aft e r a p p r o v a l The push to data transparency is promoting a number of data sharing initiatives by Pharmaceutical companies Government health agencies Non-profit consortiums Pharmaceutical Companies 1
2 EFPIA and PhRMA commit to clinical trials data transparency Data access process that pharmaceutical companies employ Company provides list of trials with data access Researcher selects trials required Researcher submits research proposal Company performs technical review of the proposal Independent Review Board considers request If approved, company provides researcher access to data Researcher discloses research results EFPIA maintains a list of data portals of member companies ClinicalStudyDataRequest.com a mult-sponsor consortium 2
3 A growing number of companies share data at clinicalstudydatarequest.com Step-by-step guide on how to request access to data from different sponsors Search for clinical studies from all sponsors List of studies from the search 3
4 Information on a particular study Select studies of interest and submit a research proposal Sections of the research plan Metrics on research proposals requesting access to patient level data 4
5 Metrics on research proposals requesting access to patient level data cont d List of approved research proposals Further details on a specific proposal The YODA Project 5
6 Data holders partnering in the YODA project Search for available clinical studies from all data holders Medtronic has provided individual participant-level data (IPD) for each of their 17 clinical trials evaluating the efficacy or safety of rhbmp-2. Johnson & Johnson has made available data from 96 clinical trials for pharmaceutical and medical device products, with the goal of expanding in the future to include consumer products. Data request review process Data request review process cont d 6
7 Summary of data requests Details of approved data requests Details of an approved research proposal AbbVie 7
8 AbbVie How to get data access AbbVie clinical trial & data sharing metrics Search for AbbVie studies in ClinicalTrials.gov Once approved, data can be downloaded to the requestor s system. Amgen Amgen How to get access to data Search for Amgen studies in ClinicalTrials.gov Submit research proposal to datasharing@amgen.com The proposal will be reviewed by internal and external review boards. Once approved, data can be downloaded to the requestor s system. 8
9 Biogen Biogen How to get access to data Search for Biogen studies in ClinicalTrials.gov Submit research proposal to WIRB-Copernicus Group (WCG) at The proposal will be reviewed by the data request review committee of WCG. Once approved, data can be downloaded to the requestor s system. Bristol-Myers Squibb Bristol-Myers Squibb How to get access to data Search for BMS studies in ClinicalTrials.gov Submit research proposal at: The proposal will be reviewed by the Duke Clinical Research Institute. Once approved, data can be downloaded to the requestor s system. 9
10 EMD Serono ment_to_responsible_clinical_trial_data_sharing.html EMD Serono How to get access to data Search for EMD Seono studies in ClinicalTrials.gov Submit research proposal via an online submission form. The proposal will be reviewed by an external board. Once approved, data will be available on EMD Serono s server that includes a statistical environment. Merck Merck How to get access to data 10
11 Merck Search for trials that have data access Merck Details of a specific trial 601 clinical trials Novo Nordisk Novo Nordisk How to get access to data Search for Novo Nordisk trials completed after 2001, in Submit research proposal by to irbsecretariat@novonordisk.com. The proposal will be reviewed by an external board. Once approved, data will be available on Novo Nordisk s server that includes a statistical environment. 11
12 Novo Nordisk Search for trials with data access Shire clinical trials Shire How to get access to data Search for Shire trials in Shire Search for trials with data access Submit research proposal by to The proposal will be reviewed by Shire. Once approved, data can be downloaded to the requestor s system. 12
13 Celgene Celgene How to get access to data Search for Celgene studies in ClinicalTrials.gov Once approved, data will be available on Celgene s analysis workspace. Pfizer Pfizer How to get access to data Search for Pfizer trials with data access in sults/ Submit research proposal at The proposal will be reviewed by an independent review panel. Pfizer will provide access to data using a secure portal designed by and hosted by SAS. 13
14 Pfizer Search for trials with data access Pfizer Summary of data requests 300+ clinical trials with data access 300+ clinical trials National Institute of Allergy and Infectious Diseases ImmPort the Immunology Database and Analysis Portal Government Health Agencies 14
15 Data available from many consortiums Collaborative Network for Clinical Research on Immune Tolerance Network Atopic Dermatitis Research Network (ADRN) Clinical Trials in Organ Transplantation (CTOT) Clinical Trials in Organ Transplantation in Children (CTOT-C) Population Genetics Analysis Program Protective Immunity for Special Populations HLA Region Genomics in Immune-mediated Diseases Maintenance of Macaque Specific Pathogen-Free Breeding Colonies Modeling Immunity for Biodefense Reagent Development for Toll-like and other Innate Immune Receptors Adjuvant Development Program Innate Immune Receptors and Adjuvant Discovery Program Human Immunology Project Consortium Non-human Primate Transplantation Tolerance Cooperative Study Group Centers of Excellence for Influenza Research and Surveillance (DMID funded) Vaccine Resource Center (NIAID Intramural) Consortium for Food Allergy Research (CoFAR) Renal and Lung Living Donors Evaluation Study (RELIVE) Accelerating Medicines Partnership, Autoimmune section Gates Foundation (?) March of Dimes (?) ImmPort Registered users can download datasets of a specific trial National Institute of Allergy and Infectious Diseases Immune Tolerance Network (ITN) TrialShare ITN TrialShare Registered users can download datasets of a specific trial 15
16 National Heart, Lung and Blood Institute BioLINCC Biologic Specimen and Data Repository BioLINCC Search for trials with data access BioLINCC Submit requests at the website for accessing datasets of a specific trial National Institute of Diabetes and Digestive and Kidney Diseases NIDDK Central Repository 16
17 NIDDK Repository Search for trials with data access NIDDK Repsitory Submit requests at the website for accessing datasets of a specific trial National Institute of Mental Health NDCT National Database for Clinical Trials related to Mental Illness NDCT Search for trials with data access 17
18 NDCT Submit requests at the website for accessing datasets of a specific trial National Institute on Drug Abuse NIDA Data Share NIDA Search for trials with data access NIDA Download datasets of a specific trial by clicking on the Data Files 18
19 ADCS Alzheimer s Disease Cooperative Study Non-profit Consortiums ADCS How to get access to data Search for ADCS trials in ADCS Search for trials with data access Submit research proposal by to ADCSdataacces@ucsd.edu. The proposal will be reviewed by ADCS Publications Comittee. Once approved, data can be downloaded to the requestor s system. 19
20 PRO-ACT Pooled Resource Open Access ALS Clinical Trials Database PRO-ACT Registered users can download datasets CAMD Coalition Against Major Diseases CAMD A collaboration of private and public institutions 20
21 CODR CAMD Alzheimer s Disease Database Project Data Sphere Project Data Sphere How to get access to data Initiative of CEO Roundtable of Cancer s Life Sciences Consortium. Project DataSphere Search for trials data available for analyses Cancer clinical trial data provided by members of Life Sciences Consortium ( Register to receive broad access to the data. SAS provides analytic tools that researches use to analyze data in Project Data Sphere s workspace. 21
22 isaec International SAE Consortium isaec Data Portal Registered users get access to datasets Sage Bionetworks support open science through public-private partnerships Sage Bionetworks Case Studies 22
23 DREAM Challenges, a non-profit, collaborative community research effort DREAM Challenges From challenges to research to publications Prostate Cancer DREAM Challenge a community research effort with open clinical trials data The Landscape of Clinical Trial Data Sharing Initiatives this is just the beginning 23
EBiSC the first European bank for induced pluripotent stem cells
Press Release EBiSC the first European bank for induced pluripotent stem cells Pharmaceutical companies who are members of the European Federation of Pharmaceutical Industries and Associations (EFPIA)
More informationDonna J. Dean, Ph.D. October 27, 2009 Brown University
Building Connections with NIH Program Officers: Myths and Realities Donna J. Dean, Ph.D. October 27, 2009 Brown University Funding Agencies Federal Agencies Focused on Biomedical Research s of Health (NIH)
More informationIn the largest and perhaps the most ambitious collaborative
FEATURES THE BIRTH OF TRANSCELERATE BIOPHARMA, INC. Revolution in Clinical Research Partnerships by Dalvir Gill and Garry Neil In the largest and perhaps the most ambitious collaborative effort ever initiated
More informationHow Public-Private Partnerships Benefit All Stakeholders Douglas C. Throckmorton, MD Deputy Director for Regulatory Programs, CDER, FDA
How Public-Private Partnerships Benefit All Stakeholders Douglas C. Throckmorton, MD Deputy Director for Regulatory Programs, CDER, FDA September 10, 2013 Outline Need for improved science in support of
More informationEuropean Statistical Workshop (EFSPI/PSI): EMA Clinical Trial Data Transparency
European Statistical Workshop (EFSPI/PSI): EMA Clinical Trial Data Transparency Dr. Christoph Gerlinger 2013-08-22 Overview How it all began Current status EFSPI s Position EMA s draft Policy Aim of this
More information6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality
6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality March 24-25, 2015 Wyndham Philadelphia Historic District, Philadelphia, PA www.exlevents.com/gcp Sponsors
More informationFY 2009. NIH Loan Repayment Programs THE INTRAMURAL LOAN REPAYMENT PROGRAMS DATA BOOK. Fiscal Year 2009 Highlights. Application Cycles:
FY 2008 2009 NIH Loan Repayment Programs THE INTRAMURAL LOAN REPAYMENT PROGRAMS DATA BOOK Fiscal Year 2009 Highlights October 1, 2008 to September 30, 2009 Application Cycles: New: September 1, 2008 -
More informationFY 2011. NIH Loan Repayment Programs THE INTRAMURAL LOAN REPAYMENT PROGRAMS DATA BOOK. Fiscal Year 2011 Highlights. Application Cycles:
FY 200181 FY 2011 NIH Loan Repayment Programs THE INTRAMURAL LOAN REPAYMENT PROGRAMS DATA BOOK Fiscal Year 2011 Highlights October 1, 2010 to September 30, 2011 Application Cycles: New: September 1, 2010
More informationKatrin Eichelberg, PhD
Katrin Eichelberg, PhD Office of Research Training and Special Programs Division of Extramural Activities, NIAID, NIH keichelberg@niaid.nih.gov June 7 th, 2013 Welcome to Bethesda! NIH 27 Institutes and
More informationNew York Bio Conference 2016. Mark J. Alles Chief Executive Officer
New York Bio Conference 2016 Mark J. Alles Chief Executive Officer Great Progress AGE 72 World Life Expectancy 2005-2014* 17 new drugs for rare diseases 71.5 71 Two new MS drugs First drug to target root
More informationYale University Open Data Access (YODA) Project Procedures to Guide External Investigator Access to Clinical Trial Data Last Updated August 2015
OVERVIEW Yale University Open Data Access (YODA) Project These procedures support the YODA Project Data Release Policy and more fully describe the process by which clinical trial data held by a third party,
More informationOracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries
Oracle Buys Phase Forward Expands Oracle s solutions for the life sciences and healthcare industries April 16, 2010 Oracle is currently reviewing the existing Phase Forward product roadmap and will be
More informationFAST TRACK DEVELOPMENT OF EBOLA VACCINES: FDA REGULATORY PERSPECTIVE
FAST TRACK DEVELOPMENT OF EBOLA VACCINES: FDA REGULATORY PERSPECTIVE Marion Gruber, Ph.D. Director Office of Vaccines Research & Review Center for Biologics Evaluation and Research US Food and Drug Administration
More informationEthics and Scientific Oversight for Phase 1 Clinical Trials in Hong Kong. Sydney TANG Chairman, HKU/HA HKW IRB November 21, 2015
Ethics and Scientific Oversight for Phase 1 Clinical Trials in Hong Kong Sydney TANG Chairman, HKU/HA HKW IRB November 21, 2015 Clinical Trials at HKU Phase 1 Phase II Phase III Phase IV Conducted on patient
More informationCHEM-E4140 Selectivity 12. Pharma Business
CHEM-E4140 Selectivity 12. Pharma Business Prof. Ari Koskinen Laboratory of Organic Chemistry C318 Pharma Business Total volume ca 1100 G$ (Shell 421G$; Walmart 486G$; Toyota 252 G$). Annually approx 25
More informationCANADIAN RULE BASED CLASSIFICATION SYSTEM (IVDD) Life Sciences British Columbia NRC-Industry Research Assistance Program
CANADIAN RULE BASED CLASSIFICATION SYSTEM (IVDD) Life Sciences British Columbia NRC-Industry Research Assistance Program Health Canada Regulations on Medical Devices Vancouver, B.C. October 29, 2007 Nancy
More informationCRISP1 Data Archive. The NIDDK Repository offers the following three data packages from the CRISP1 study:
CRISP1 Data Archive The NIDDK Repository offers the following three data packages from the CRISP1 study: 1. The standard data archive, which contains a dataset compiled by the Data Center, Center for Research
More informationClinical Trial Data Sharing
Clinical Trial Data Sharing NPA FDA Taskforce Meeting December 15, 2014 Joseph S. Ross, MD, MHS Section of General Internal Medicine, School of Medicine Center for Outcomes Research and Evaluation, Yale-New
More informationPCORI Evaluation Group. Tenth Meeting November 5, 2014
PCORI Evaluation Group Tenth Meeting November 5, 2014 Agenda for Today Recap from 10/15 meeting: Status updates Communicating about PCORI evaluation work Focus on topic capture and research prioritization
More informationAssessing the research potential of access to clinical trial data: Summary
Access to Clinical Trial Data Assessing the research potential of access to clinical trial data: Summary March 2015 Access to Clinical Trial Data Assessing the research potential of access to clinical
More informationGenetic Alliance BioBank: A Virtual Tour of Registry Solutions to Accelerate Research February 22, 2010
Genetic Alliance BioBank: A Virtual Tour of Registry Solutions to Accelerate Research February 22, 2010 Liz Horn Genetic Alliance Posted in the Resource Repository at: http://www.resourcerepository.org/documents/1872/geneticalliancebiobank:avirtualto
More informationBRISTOL-MYERS SQUIBB DATA DISCLOSURE & TRANSPARENCY
BRISTOL-MYERS SQUIBB DATA DISCLOSURE & TRANSPARENCY TRUSTED COMPANY Since 2001, Sylogent systems have been utilized by leading BioPharma companies Publication Planning Data Disclosure & Transparency Study
More informationDevelopment of Advanced Healthcare Systems in Australia. Professor Stephen Smith Dean
Development of Advanced Healthcare Systems in Australia Professor Stephen Smith Dean 7 April 2014 Global Comparison (2012 Data) Australia Population (millions) 22.3 GDP (US$ billions) 1541.8 GDP per capita
More informationEHR OpenNESS: Innovation and Uptake
EHR OpenNESS: Innovation and Uptake Kenneth D. Mandl, MD, MPH Director, Intelligent Health Laboratory Children s Hospital Informatics Program Center for Biomedical Informatics Harvard Medical School To
More informationHealth Innovation. Innovation for health includes the. diagnostics and medical devices, as
BIO-INNOVATION Health Innovation Innovation for health includes the development of new drugs, vaccines, diagnostics and medical devices, as well as new techniques in process engineering and manufacturing,
More informationRoche Position on Human Stem Cells
Roche Position on Human Stem Cells Background Stem cells and treating diseases. Stem cells and their applications offer an enormous potential for the treatment and even the cure of diseases, along with
More informationOutcomes of Monitoring Committee Reviews. Medicines Australia Code of Conduct
Outcomes of Monitoring Committee Reviews Medicines Australia Code of Conduct 1 Medicines Australia ABN 23 126 990 001 Level 1, 16 Napier Close Deakin ACT 2600 Phone: 02 6122 8500 Fax: 02 6122 8555 Web:
More informationDecision to Continue the Development of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer to be Announced
September 27, 2013 ONO PHARMACEUTICAL CO., LTD. Corporate Communications Phone: +81-6-6263-5670 Decision to Continue the Development of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer to be Announced
More informationWhat Lies Ahead? Trends to Watch: Health Care Product Development in North America
What Lies Ahead? Trends to Watch: Health Care Product Development in North America What Lies Ahead? for 2015 DIA has released its third annual What Lies Ahead? report, providing experts insights into the
More informationGlobal Non-Small Cell Lung Cancer Therapeutics Market 2015-2019
Brochure More information from http://www.researchandmarkets.com/reports/3453273/ Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 Description: About non-small cell lung cancer therapeutics
More informationNIH. National Institute of Allergy and Infectious Diseases SIGNIFICANT ITEMS IN HOUSE AND SENATE APPROPRIATIONS COMMITTEE REPORTS
NIH National Institute of Allergy and Infectious Diseases SIGNIFICANT ITEMS IN HOUSE AND SENATE APPROPRIATIONS COMMITTEE REPORTS FY 2006 House Appropriations Committee Report Language (H. Rpt. 109-143)
More informationFunded by NIH for~30 Years
Funded by NIH for~30 Years NIMH NHLBI NHGRI NIAMS ORDR NIH Office of the Director ORIP NCI OD NEI NIDDK NIAID NDRI Rare Disease Biospecimen Program Penn Medicine Center for Orphan Disease Research & Therapy
More informationRanking Member Subcommittee on Labor-HHS-Education Subcommittee on Labor-HHS-Education. Washington, DC 20515 Washington, DC 20515
THE AD HOC GROUP FOR MEDICAL RESEARCH The Honorable David Obey The Honorable Todd Tiahrt Chair Ranking Member Subcommittee on Labor-HHS-Education Subcommittee on Labor-HHS-Education United States House
More informationDisclosures. Advisory Boards: Speaker Bureaus: Janssen, Gilead, AbbVie. Janssen, Gilead, AbbVie, Bristol-Myers Squibb, Entera Health, Salix
Disclosures Advisory Boards: Janssen, Gilead, AbbVie Speaker Bureaus: Janssen, Gilead, AbbVie, Bristol-Myers Squibb, Entera Health, Salix Outline Assess patient readiness for treatment Examine various
More informationAn Introduction to Genomics and SAS Scientific Discovery Solutions
An Introduction to Genomics and SAS Scientific Discovery Solutions Dr Karen M Miller Product Manager Bioinformatics SAS EMEA 16.06.03 Copyright 2003, SAS Institute Inc. All rights reserved. 1 Overview!
More informationClinical Trial Data Transparency Environment & Expectations EMA Policy - Clinical Trials Regulation
Clinical Trial Data Transparency Environment & Expectations EMA Policy - Clinical Trials Regulation Joint BBS-EFSPI Seminar, Basel, 13 Nov 2014 Sabine Atzor, Head of EU Regulatory Policies PDR Overview
More informationThe Human Genome Project. From genome to health From human genome to other genomes and to gene function Structural Genomics initiative
The Human Genome Project From genome to health From human genome to other genomes and to gene function Structural Genomics initiative June 2000 What is the Human Genome Project? U.S. govt. project coordinated
More informationHOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA CONSENT TO PARTICIPATE IN A RESEARCH STUDY AND RESEARCH SUBJECT HIPAA AUTHORIZATION
CONSENT TO PARTICIPATE IN A RESEARCH STUDY AND RESEARCH SUBJECT HIPAA AUTHORIZATION Protocol Title: A5322, Version 2.0, 01/28/15 Long-term Follow-up of Older HIV-infected Adults in the ACTG: Addressing
More informationOctober 17, 2005. Elias Zerhouni, M.D. Director National Institutes of Health One Center Drive Suite 126 MSC 0148 Bethesda, MD 20892
October 17, 2005 Elias Zerhouni, M.D. Director National Institutes of Health One Center Drive Suite 126 MSC 0148 Bethesda, MD 20892 Dear Dr. Zerhouni: The undersigned nonprofit medical and scientific societies
More informationEvidence-Based Practice for Public Health Identified Knowledge Domains of Public Health
1 Biostatistics Statistical Methods & Theory Evidence-Based Practice for Public Health Identified Knowledge Domains of Public Health General Public Health Epidemiology Risk Assessment Population-Based
More informationSome Biomedical Informatics Programs at NIBIB and NIH
Some Biomedical Informatics Programs at NIBIB and NIH BIBM 2009 November 3, 2009 Zohara Cohen, PhD of Biomedical Imaging & Bioengineering NIH, DHHS Training Grants and Fellowships: Career Development Awards
More informationClinical Trials: Improving the Care of People Living With Cancer
CLINICAL TRIALS Clinical Trials: Improving the Care of People Living With Cancer Presented by Mary McCabe, RN, MA Memorial Sloan-Kettering Cancer Center Carolyn Messner, DSW CancerCare Learn about: Stages
More informationProceedings Promoting Clinical Trial Data Transparency Conference
Proceedings Promoting Clinical Trial Data Transparency Conference 30-31 March, 2015 Harvard Faculty Club Cambridge, MA Table of Contents Executive Summary... 4 Introduction... 4 Pre-Conference Survey...
More informatione-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015
e-labeling : innovation for patient or regulation nightmare Pharmapack Feb, 11 th, 2015 PHARMAPACK 2015 1 Mobile health x2 30 months 100 000 mapps Source: research2guidance, mhealth App Market Report 2013-2017
More informationPrognosis for Healthcare: The Future of Medicine
Prognosis for Healthcare: The Future of Medicine Bruce M. Cohen, M.D., Ph.D. Director, Frazier Research Institute, McLean Hospital President and Psychiatrist in Chief Emeritus, McLean Hospital Robertson-Steele
More informationGraduation Day. Congratulations You re an Information Manager! Paula Brown Stafford President, Clinical Development
Graduation Day Congratulations You re an Information Manager! Paula Brown Stafford President, Clinical Development Welcome Information Management Graduates Who we were Managing data way back when Who we
More informationGRADUATE RESEARCH PROGRAMMES (MSc and PhD) AY2015/2016 MODULE DESCRIPTION
GRADUATE RESEARCH PROGRAMMES (MSc and PhD) AY2015/2016 MODULE DESCRIPTION CORE MODULES CO5102 Principles of Epidemiology (for both MSc and PhD) This module introduces students to the tools for describing
More informationCCAC Animal Data Report
2013 CCAC Animal Data Report Canadian Council on Animal Care Conseil canadien de protection des animaux ACKNOWLEDGMENTS The CCAC extends its sincere thanks to all those responsible for submitting annual
More informationBOLT Hem/Onc Thought Leader Panel #38 Cancer Immunotherapy 2014-05
Syndicated Thought Leader Insight Healthcare & Pharmaceutical Research Cancer Immunotherapy Melanoma, Non- Small Cell Lung Cancer, Renal Cell Carcinoma Thought Leader Panel #38 2014-05 Therapeutic Area:
More informationClinical Trial Transparency: An IT Perspective By Vijai Krishna
www.hcltech.com Clinical Trial Transparency: An IT Perspective By Vijai Krishna WHITEPAPER April 2015 TABLE OF CONTENTS INTRODUCTION 3 ROLE OF IT IN CLINICAL TRIAL TRANSPARENCY INITIATIVE (CTTI): AN INDUSTRY
More informationFY 2014 The NIH Extramural Loan Repayment Programs Data Book
FY 2014 The NIH Extramural Loan Repayment Programs Data Book FISCAL YEAR 2014 HIGHLIGHTS October 1, 2013 to September 30, 2014 APPLICATION CYCLE: New and Renewal : September 1, 2013 December 2, 2013 2015
More informationWhat s Next for Data Sharing: Insight from the NIH Experience
What s Next for Data Sharing: Insight from the NIH Experience Jerry Sheehan Assistant Director for Policy Development National Library of Medicine National Institutes of Health SHARE In-Person Meeting
More informationIt s not something you want to think about, but it s something you want to prepare for.
It s not something you want to think about, but it s something you want to prepare for. StemCyte cord blood banking offers your family a new lifesaving treatment alternative Why Bank Take the once-in-alifetime
More informationBrad H. Pollock, MPH, PhD
Biostatistician s Perspective: Roles in Observational Studies, Electronic Health Records & Big Data Brad H. Pollock, MPH, PhD Professor and Chairman, Dept. of Epidemiology & Biostatistics, School of Medicine,
More informationNICHD Extramural Associates Program Partnerships for Emerging Research Institutions The National Academies September 13, 2007
NICHD Extramural Associates Program Partnerships for Emerging Research Institutions The National Academies September 13, 2007 Regina Smith James, M.D. Director, Extramural Associates Program NICHD, NIH,
More informationSimple, Affordable & SAFE!
The Insurance & Benefits Trust of PORAC Simple, Affordable & SAFE! Group Term Life Insurance Application (10-Year Level Term Rate) Group Term Life Application for 10-Year Level Term Rate Reference to Spouse
More informationAgenda Item 3. Discovery to Product Accelerator
Agenda Item 3 Discovery to Product Accelerator BOARD OF REGENTS SUMMARY OF ITEM FOR ACTION INFORMATION OR DISCUSSION TOPIC: Discovery to Product Accelerator (information item) COMMITTEE: Economic Development
More informationASCO Initiatives in Personalized Medicine. Richard L. Schilsky, MD, FACP, FASCO Chief Medical Officer American Society of Clinical Oncology
ASCO Initiatives in Personalized Medicine Richard L. Schilsky, MD, FACP, FASCO Chief Medical Officer American Society of Clinical Oncology Financial Disclosures No financial relationships to disclose.
More informationMedical Communication Companies and Industry Grants
Research Brief Report Communication Companies and Industry Grants Sheila M. Rothman, PhD; Karen F. Brudney, MD; Whitney Adair, BA; David J. Rothman, PhD IMPORTANCE communication companies (MCCs) are among
More informationPHFAST Public Health Framework ASsessment Tool Adapted from the Public Health Framework for Action and STAR
LEADERSHIP: The state chronic disease prevention and control unit is the unifying voice for the prevention and control of chronic diseases. LS1 LS2 LS3 LS4 LS5 The unit is a key contact for others both
More informationNIH Perspectives and Priorities Story C. Landis, PhD Director, NINDS January 10, 2011
The Public Health Dimensions of the Epilepsies NIH Perspectives and Priorities Story C. Landis, PhD Director, NINDS January 10, 2011 The National Institutes of Health (NIH) Mission: To seek fundamental
More informationImmuno-Oncology Therapies to Treat Lung Cancer
Immuno-Oncology Therapies to Treat Lung Cancer What you need to know ONCHQ14NP07519 Introduction: Immuno-oncology represents an innovative approach to cancer research that seeks to harness the body s own
More informationEnabling Discovery, Development, and translation of treatments for Cognitive Dysfunctions in Depression: A Workshop Session IV
Enabling Discovery, Development, and translation of treatments for Cognitive Dysfunctions in Depression: A Workshop Session IV Maria Isaac, MASc, MD, PhD, MFPM, Psychiatrist Senior Scientific Officer Institute
More informationHARTFORD LIFE AND ACCIDENT INSURANCE COMPANY Simsbury, Connecticut 06089 Section 1
GROUP LIFE INSURANCE APPLICATION HARTFORD LIFE AND ACCIDENT INSURANCE COMPANY Simsbury, Connecticut 06089 Section 1 Policyholder: American College of Emergency Physicians Policy No.: AGL-1905 Certificate
More informationSmall-Cell Lung Cancer Global Clinical Trials Review, H2, 2015
Brochure More information from http://www.researchandmarkets.com/reports/3398017/ Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015 Description: Small-Cell Lung Cancer Global Clinical Trials
More informationJanuary 1, 2011 FUNDING OPPORTUNITIES: Featured Funding Opportunities
January 1, 2011 FUNDING OPPORTUNITIES: Featured Funding Opportunities Find NIH Grants: Search Active Grants http://grants.nih.gov/grants/guide/index.html Weekly Grant ListServ: http://grants.nih.gov/grants/guide/listserv.htm
More informationEnding cancer. Together.
Ending cancer. Together. Making History by Being First To achieve something as big and bold as ending cancer requires the courage to be first and a willingness to partner with others. At the Robert W.
More informationSimple, Affordable & SAFE!
California State Firefighters Employee Welfare Benefits Corporation Simple, Affordable & SAFE! Limited Time Simplified Issue Offer Group Term Life Insurance Application (10-Year Level Term Rate) C2 ReliaStar
More informationHealth Care 2.0: How Technology is Transforming Health Care
Health Care 2.0: How Technology is Transforming Health Care Matthew Kaiser, CEBS, SPHR Director, HR Technology and Outsourcing Lockton Kansas City, Missouri The opinions expressed in this presentation
More informationObtaining Funding in Clinical Research
Obtaining Funding in Clinical Research Ellen Seely, MD Director of Clinical Research Endocrinology, Diabetes and Hypertension Division Vice Chair, Faculty Development, Department of Medicine Brigham and
More informationFINDING PROTEINS THAT HIT THE MARK PROVEN TRACK-RECORD OF PROTEOMICS EXPERTISE
FINDING PROTEINS THAT HIT THE MARK PROVEN TRACK-RECORD OF PROTEOMICS EXPERTISE Bioanalytical Services Fit-for-Purpose Assays Biomarker Discovery and Development Proven track-record of proteomics expertise
More informationActionable Insights into Health Policy, Practice and Outcomes Through Research and Big Data - with a Spotlight on Oncology
Actionable Insights into Health Policy, Practice and Outcomes Through Research and Big Data - with a Spotlight on Oncology Attend the Virtual Meeting in HE-Xpo Wednesday, Feb. 18, 2015 Session One: 9:30
More informationIronPort Gateway Security Products The Leader in Communication Security Reiner Baumann IronPort Systems The Principles of Industry Leadership A n a l y s t L e a d e r s h i p R e c o g n i z e d a s t
More informationJune 28-29 Washington, DC SPONSORSHIP OPPORTUNITIES
June 28-29 Washington, DC SPONSORSHIP OPPORTUNITIES OVERVIEW Due rising out-of-pocket consumer healthcare costs, the recently passed healthcare reform legislation, and new technology innovation, the healthcare
More informationAustralia Life Sciences Market
Australia Life Sciences Market Monique Roos, Commercial Specialist U.S. Commercial Service, Sydney, Australia November 2014 Geographical Size Population Density More than 80% of population in this ring
More informationPatient Centricity and the Changing Landscape of Healthcare
Patient Centricity and the Changing Landscape of Healthcare Andrea Cotter Director Healthcare Marketing IBM Corporation IBM Healthcare and Life Sciences Patient Centricity and the Changing Landscape of
More informationThe Blood Donor BIOBANK
The Blood Donor BIOBANK the first successful combination of blood donation and biobanking for medical research 1 1 Zoglmeier et al., TRANSFUSION 2011, 51(5): 1121-1122 Dr. Franz Weinauer SWISSTRANSFUSION
More informationA Guide for Successfully Completing the Group Disability Insurance Evidence of Insurability Form
A Guide for Successfully Completing the Group Disability Insurance Evidence of Insurability Form Mutual of Omaha appreciates the opportunity to provide you with valuable income protection. So that we can
More informationHealth Information Exchange in NYS
Health Information Exchange in NYS Roy Gomes, RHIT, CHPS Implementation Project Manager 1 Who is NYeC? 2 Agenda NYeC Background Overview and programs Assist providers transitioning from paper to electronic
More informationTo know more about Pharmacovigilance and Clinical Trials Data Management
To know more about Pharmacovigilance and Clinical Trials Data Management 1. What is Pharmacovigilance? Pharmacovigilance (PV) is the pharmacological science related to the detection, assessment, understanding
More informationIMI2 Call 5 topics. Hugh Laverty, IMI Senior Scientific Project Manager Webinar FFG Austria 16 July 2015
IMI2 Call 5 topics Hugh Laverty, IMI Senior Scientific Project Manager Webinar FFG Austria 16 July 2015 IMI 2 Call 5 topics Patient perspective elicitation on benefits and risks of medicinal products from
More informationPharmacology skills for drug discovery. Why is pharmacology important?
skills for drug discovery Why is pharmacology important?, the science underlying the interaction between chemicals and living systems, emerged as a distinct discipline allied to medicine in the mid-19th
More informationGraduate Fellowships. Preparing the leaders of tomorrow. school of medicine. The Campaign for Washington University
Graduate Fellowships Preparing the leaders of tomorrow school of medicine The Campaign for Washington University Together, we change lives. Washington University educates and trains outstanding scientists
More informationAssureImmune. Cord Blood: For Something That Precious, Bank with the Best. Important Facts for When You re Expecting. AssureImmune.
AssureImmune AssureImmune Cord Blood: For Something That Precious, Bank with the Best Important Facts for When You re Expecting Banking your baby s umbilical cord blood could be a potentially lifesaving
More informationTRACKS GENETIC EPIDEMIOLOGY
Dr. Priya Duggal, Director In the post-genomic era where larger amounts of genetic data are now readily available, it has become increasingly important to design studies and use analytical techniques that
More informationLibyan International Medical University www.limu.edu.ly PBL-III. ZuhirBodalal
Libyan International Medical University www.limu.edu.ly PBL-III ZuhirBodalal Disclaimer The following is a collection of medical information from multiple sources, both online and offline. It is to be
More informationWorkshop on Establishing a Central Resource of Data from Genome Sequencing Projects
Report on the Workshop on Establishing a Central Resource of Data from Genome Sequencing Projects Background and Goals of the Workshop June 5 6, 2012 The use of genome sequencing in human research is growing
More informationSTORED TISSUE SAMPLE WEB SITES
Appendix J STORED TISSUE SAMPLE WEB SITES Advanced Fertility Center of Chicago Alabama Community Blood Bank Alabama Eye Bank Alabama Organ Center Alzheimer Center Case Western Reserve University Alzheimer
More informationP.O. Box 91120, MS 295 Seattle, WA 98111-9220 1-800-752-6663 Fax: 425-918-5278
Washington Medicare Supplement Enrollment Application for Plans A, F, High Deductible F and N P.O. Box 91120, MS 295 Seattle, WA 98111-9220 1-800-752-6663 Fax: 425-918-5278 ou are eligible to apply for
More informationWhat to Expect in Next Year & Developing Your ACO Action Plan
What to Expect in Next Year & Developing Your ACO Action Plan Welcome The webinar will start at 3:00 pm ET. It is interactive, so please make sure that you have connected via phone with your audio pin.
More informationA PATIENT S GUIDE Understanding Your Healthcare Benefits
A PATIENT S GUIDE Understanding Your Healthcare Benefits This guide includes useful information about how health insurance works and the reimbursement process used to pay for treatments. TABLE OF CONTENTS
More informationHow To Plan Healthy People 2020
Healthy California 2020 Initiative: Consensus Building on Top Priority Areas for CDPH Public Health Advisory Committee April 30, 2010 Introducing the CDPH Decision Framework Responding to public health
More informationIPROVE Innovation Partnership for a Roadmapon VaccinesinEurope
IPROVE Innovation Partnership for a Roadmapon VaccinesinEurope IPROVE IN BRIEF What is IPROVE? Whydo we need IPROVE? IPROVE in actions (How?) Partnership (Who?) WHAT An EU project (FP7) financed by the
More informationPersonal Contact and Insurance Information
Kenneth A. Holt, M.D. 3320 Executive Drive Tele: 919-877-1100 Building E, Suite 222 Fax: 919-877-8118 Raleigh, NC 27609 Personal Contact and Insurance Information Please fill out this form as completely
More informationJoint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009
Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009 The innovative pharmaceutical industry 2 is committed to the transparency
More informationHealth Insurance Carriers Can Restrict Recruitment on a Randomized Clinical Trial of Stem Cell Transplant for Autoimmune Disease
Health Insurance Carriers Can Restrict Recruitment on a Randomized Clinical Trial of Stem Cell Transplant for Autoimmune Disease Keith M Sullivan, M.D. Duke University Medical Center For the SCOT (Scleroderma:
More informationHow Can Institutions Foster OMICS Research While Protecting Patients?
IOM Workshop on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials How Can Institutions Foster OMICS Research While Protecting Patients? E. Albert Reece, MD, PhD, MBA Vice
More informationIf you were diagnosed with cancer today, what would your chances of survival be?
Q.1 If you were diagnosed with cancer today, what would your chances of survival be? Ongoing medical research from the last two decades has seen the cancer survival rate increase by more than 40%. However
More informationGlobal Monoclonal Antibodies Pipeline Insight 2015
Brochure More information from http://www.researchandmarkets.com/reports/3113388/ Global Monoclonal Antibodies Pipeline Insight 2015 Description: Ever since the Nobel Prize was bestowed on the person who
More information